<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>iGEM 2025 | Granulyze ALS Project</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=DM+Serif+Display&family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
<style>
:root {
  --primary: #7aa7ff;
  --primary-dark: #557fd6;
  --background: #fafcff;
  --surface: #ffffff;
  --text-main: #1e293b;
  --text-muted: #64748b;
  --border: #e2e8f0;
}
* { box-sizing: border-box; margin:0; padding:0; }
body { font-family:'Inter', sans-serif; background:var(--background); color:var(--text-main); line-height:1.7; padding:2rem; }
.section { margin-bottom:4rem; opacity:0; transform:translateY(30px); transition:opacity 0.8s ease, transform 0.8s ease; }
.section.visible { opacity:1; transform:translateY(0); }
h1,h2,h3 { font-family:'DM Serif Display', serif; color:var(--primary-dark); margin-bottom:1rem; }
h1{ font-size:2.8rem; }
h2{ font-size:2.2rem; }
h3{ font-size:1.4rem; margin-top:1.5rem; }
p{ color:var(--text-muted); margin-bottom:1rem; font-size:1rem; }
.number-emphasis{ font-size:3rem; font-weight:700; color:var(--primary); margin:0.5rem 0; }
.placeholder-img{ width:100%; border:2px dashed var(--border); border-radius:12px; text-align:center; padding:2rem; color:var(--text-muted); font-size:0.95rem; margin-top:1.5rem; }
.solution-block{ border-left:5px solid var(--primary); padding-left:1rem; margin-top:1.5rem; }
footer{ margin-top:6rem; border-top:1px solid var(--border); padding-top:1.8rem; text-align:center; font-size:0.9rem; color:var(--text-muted);}
</style>
</head>
<body>

<div class="section" id="impact">
  <h1>Every 90 minutes, someone is diagnosed with and passes from Amyotrophic Lateral Sclerosis (ALS)</h1>
  <div class="number-emphasis">90</div>
  <h2>Life expectancy post-diagnosis</h2>
  <div class="number-emphasis">48 months (~4 years)</div>
  <h2>Predicted global increase by 2040</h2>
  <div class="number-emphasis">70%</div>
  <div class="placeholder-img">Hover map placeholder: Expected ALS statistics 2015 → 2040</div>
</div>

<div class="section" id="mechanism">
  <h2>Cellular Mechanism in ALS</h2>
  <p>Under cellular stress, Stress Granules (SGs) become dysfunctional and form additional "organelles". Excessive SG formation is linked to pathological TDP-43 protein aggregation in neurons.</p>
  <div class="placeholder-img">Cell with stress granules illustration</div>
  <div class="placeholder-img">TDP-43 aggregate illustration</div>
</div>

<div class="section" id="solution">
  <h2>Our Dual-Approach Solution</h2>
  <div class="solution-block">
    <h3>Antisense Oligonucleotide Therapy</h3>
    <p>Novel antisense oligonucleotides knock down proteins implicated in stress granule formation.</p>
  </div>
  <div class="placeholder-img">Antisense oligonucleotide therapy illustration</div>
  <div class="solution-block">
    <h3>RNA Aptamer Therapy</h3>
    <p>Computational modeling and in-vitro testing created RNA aptamers that prevent TDP-43 aggregate formation.</p>
  </div>
  <div class="placeholder-img">RNA aptamer therapy illustration</div>

  <h2>Before vs. After Therapy</h2>
  <div class="placeholder-img">Before therapy illustration</div>
  <div class="placeholder-img">After therapy illustration</div>
</div>

<div class="section" id="promo">
  <h2>Watch Our Promotional Video</h2>
  <div class="placeholder-img">Embedded video placeholder</div>
</div>

<div class="section" id="references">
  <h2>References</h2>
  <ul>
    <li>University of Michigan Health – ALS Facts & Figures</li>
    <li>Nature Communications, 2016 – TDP-43 and Stress Granules</li>
    <li>Frontiers in Cellular Neuroscience, 2020 – TDP-43 Pathology Overview</li>
    <li>Experimental & Molecular Medicine, 2020 – SGs and Neurodegeneration</li>
  </ul>

  <h2>Community Supporters</h2>
  <div class="placeholder-img">Sponsor logos placeholder: IDT, Qualcomm, UCSD, Sanford Burnham Prebys, ALS San Diego</div>

  <h3>Contact Us</h3>
  <p>Email: delnorteigem@gmail.com</p>
  <p>Address: 16601 Nighthawk Ln, San Diego, CA 92127</p>
  <p>Instagram: @dnhsigem</p>
</div>

<footer>
  © 2025 – Content licensed under Creative Commons Attribution 4.0 International.
</footer>

<script>
const sections = document.querySelectorAll('.section');
const observer = new IntersectionObserver(entries => {
  entries.forEach(entry => { if(entry.isIntersecting){ entry.target.classList.add('visible'); } });
}, { threshold:0.15 });
sections.forEach(section => observer.observe(section));
</script>

</body>
</html>